During a session at the this week’s World Stem Cell Summit in San Diego, an international research team described an “astonishing” experiment in which a mouse model of multiple sclerosis was able to virtually totally recover and move normally after being transplanted with human neural precursor cells (hNPC). The scientists were able to show almost full recovery in the mice up to six months later.
Recent Posts
- Socioeconomic Barriers Limit Access to Lifesaving Stem Cell Transplants in AML
- Newly discovered mechanism in the cell’s energy factory can lead to new treatment of muscle disorders
- New drug tested to reduce side effect of ‘half-matched’ stem cell transplants
- Gene and Cell Therapies Take Aim at Parkinson’s Disease
- Health Net grant for UC Davis Stem Cell Program to improve access to CAR T-cell therapy
- Stem cell therapy TED-A9 showing safety and early efficacy in trial